Skip to content
PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 625

625. Deputy Catherine Callaghan asked the Minister for Health if she will provide an update on the progress of the Full Health Technology Assessment (HTA) for a drug (details supplied) for the treatment of eosinophilic oesophagitis, which was commissioned by the HSE on 25 June 2024, when the assessment is expected to be completed and whether consideration is being given to making this drug available under the Medical Card Scheme, Drugs Payment Scheme or other community drug reimbursement arrangements, given its importance for patients living with this chronic condition. [67023/26]

askedIreland· Dáil Éireann· EN

Introduced

22 September 2026

Last action

22 September 2026 · Medicinal Products

Status

written

Sponsors

Catherine Callaghan

Subjects

Discovery layer

Source updated

22 September 2026

Summary

625. Deputy Catherine Callaghan asked the Minister for Health if she will provide an update on the progress of the Full Health Technology Assessment (HTA) for a drug (details supplied) for the treatment of eosinophilic oesophagitis, which was commissioned by the HSE on 25 June 2024, when the assessment is expected to be completed and whether consideration is being given to making this drug available under the Medical Card Scheme, Drugs Payment Scheme or other community drug reimbursement arrangements, given its importance for patients living with this chronic condition. [67023/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 22 September 2026

    Medicinal Products

    625. Deputy Catherine Callaghan asked the Minister for Health if she will provide an update on the progress of the Full Health Technology Assessment (HTA) for a drug (details supplied) for the treatment of eosinophilic oesophagitis, which was commissioned by the HSE on 25 June 2024, when the assessment is expected to be completed and whether consideration is being given to making this drug available under the Medical Card Scheme, Drugs Payment Scheme or other community drug reimbursement arrangements, given its importance for patients living with this chronic condition. [67023/26]

    Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products

View fileDownload file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.